These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of indolent cutaneous B‑cell lymphoma]. Wobser M Hautarzt; 2017 Sep; 68(9):721-726. PubMed ID: 28766120 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey. Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma: a rare and aggressive cutaneous lymphoma. Vermeesch J; Ramirez J; Lafond A Cutis; 2018 Dec; 102(6):421-424. PubMed ID: 30657800 [TBL] [Abstract][Full Text] [Related]
5. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma. Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly]. Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Management of Cutaneous B-Cell Lymphomas. Malachowski SJ; Sun J; Chen PL; Seminario-Vidal L Dermatol Clin; 2019 Oct; 37(4):443-454. PubMed ID: 31466585 [TBL] [Abstract][Full Text] [Related]
8. [Cutaneous lymphomas: new entities and rare variants]. Kempf W; Mitteldorf C Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Ok CY; Li L; Xu-Monette ZY; Visco C; Tzankov A; Manyam GC; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Chen J; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ai W; Ponzoni M; Ferreri AJ; Farnen JP; Møller MB; Bueso-Ramos CE; Miranda RN; Winter JN; Piris MA; Medeiros LJ; Young KH Clin Cancer Res; 2014 May; 20(9):2338-49. PubMed ID: 24583797 [TBL] [Abstract][Full Text] [Related]
10. Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Zoroquiain P; González S; Molgó M; Rodríguez A; Valbuena JR Am J Dermatopathol; 2012 May; 34(3):330-4. PubMed ID: 22197862 [TBL] [Abstract][Full Text] [Related]
11. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly. Wang E; Papavassiliou P; Sebastian S Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous B-Cell Lymphomas. Villasenor-Park J; Chung J; Kim EJ Hematol Oncol Clin North Am; 2024 Oct; 38(5):1111-1131. PubMed ID: 39048407 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676 [TBL] [Abstract][Full Text] [Related]
14. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM Am J Hematol; 2016 May; 91(5):529-37. PubMed ID: 27093913 [TBL] [Abstract][Full Text] [Related]
15. [Cutaneous lymphoma]. Beyeler M; Burg G; Dummer R Hautarzt; 2004 Oct; 55(10):1005-16; quiz 1017. PubMed ID: 15349694 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428 [TBL] [Abstract][Full Text] [Related]
17. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Beltran BE; Castro D; Paredes S; Miranda RN; Castillo JJ Am J Hematol; 2020 Apr; 95(4):435-445. PubMed ID: 32072672 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Wilcox RA Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522 [TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
20. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Beltran BE; Castillo JJ; Morales D; de Mendoza FH; Quinones P; Miranda RN; Gallo A; Lopez-Ilasaca M; Butera JN; Sotomayor EM Am J Hematol; 2011 Aug; 86(8):663-7. PubMed ID: 21761432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]